Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.

ABSTRACT:

Background

Information is limited regarding utilization patterns and costs for chronic kidney disease-mineral and bone disorder (CKD-MBD) medications in Medicare Part D-enrolled dialysis patients.

Study design

Retrospective cohort study.

Setting & participants

Annual cohorts of dialysis patients, 2007-2010.

Predictors

Cohort year, low-income subsidy status, and dialysis provider.

Outcomes

Utilization and costs of prescription phosphate binders, oral and intravenous vitamin D analogues, and cinacalcet.

Measurements

Using logistic regression, we calculated adjusted odds of medication use for low-income subsidy versus non-low-income subsidy patients and for patients from various dialysis organizations, and we report per-member-per-month and average o

SUBMITTER: Yusuf AA 

PROVIDER: S-EPMC4209315 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature